The histopathology of transgenes and knockouts in the mammary gland

Advances in Oncobiology

Volumn 2, Issue C, 1999, Pages 177-202

  Cardiff, Robert D ^a   Munn, Robert J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957053963     PISSN: 1569254X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-254X(98)80009-5     Document Type: Review

References (88)

1. Allred D.C., Clark G.M., Molina R., Tandon A.K., Schnitt S.J., Gilchrist K.W., Osborne C.K., Tormey D.C., and McGuire W.L. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum. Pathol. 23 (1992) 974-999
2. Barnes D.M., Bartkova J., Camplejohn R.S., Gullick W.J., Smith P.J., and Millis R.R. Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?. Eur. J. Cancer 28 (1992) 644-648
3. Bartkova J., Barnes D.M., Millis R.R., and Gullick W.J. Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ. Hum. Pathol. 21 (1990) 1164-1167
4. Bouchard L., Lamarre L., Tremblay P.J., and Jolicoeur P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57 (1989) 931-936
5. Callahan R. MMTV-induced mutations in mouse mammary tumors: their potential relevance to human breast cancer. Breast Cancer Res. Treat. 39 1 (1996) 33-44
6. Callahan R., and Campbell G. Mutations in human breast cancer: an overview. J. Natl. Cancer Inst. 81 23 (1989) 1780-1786
7. Callahan R. Oncogenes and breast cancer progression. Basic Life Sci. 57 (1991) 143-153
8. Cardiff R.D., and Muller W.J. Transgenic mouse models of mammary tumorigenesis. Cancer Surveys 16 (1993) 97-137
9. Cardiff R.D., Ornitz D., Lee F., Moreadith R., Sinn E., Muller W., and Leder P. Mammary Morphogenesis and Oncogenes. In: Dogliotti L., Sapino A., and Bussolati G. (Eds). Breast Cancer: Progress in Biology, Clinical Management and Prevention (1992), Kluwer Acad. Publ., New York 41-55
10. Cardiff R.D., Sinn E., Muller W., and Leder P. Transgenic oncogene mice: Tumor phenotype predicts genotype. Am. J. Path. 139 (1991) 495-501
11. Cardiff R.D., and Munn R.J. Comparative pathology of mammary tumorigenesis in transgenic mice. Cancer Letters 90 (1995) 13-19
12. Cardiff R.D. Protoneoplasia: The molecular biology of mouse mammary hyperplasia. Adv. Cancer Res. 42 (1984) 167-190
13. Cardiff R.D., and Aguilar-Cordova E. Protoneoplasia Revisited: The molecular biology of mouse mammary hyperplasia. Anticancer Res. 8 5 (1988) 925-933
14. Cardiff R.D. Cellular and molecular aspects of neoplastic progression in the mammary gland. Eur J. Can and Clin. Oncol. 24 (1988) 15-20
15. Cardiff R.D. Understanding transgenes in mammary tumorigenesis: Five Rules. J. Mam. Gland Bio. Neo. 1 (1995) 61-73
16. Cardiff R.D., Morris D.W., Young L.J.T., and Strange R. MuMTV genotype, protoneoplasia, and tumor progression. In: Rich M., Hager J., and Taylor-Papdimitriou J. (Eds). Breast Cancer: Origins, Detection and Treats (1986), M. Nijhoff Publishing, Boston 156-166
17. Cardiff R.D., Wellings S.R., and Faulkin L.J. Biology of breast preneoplasia. Cancer 39 (1977) 2734-2746
18. Cheung A., Chen P., Young L., Chao C., Ndoye A., Kong A., and Cardiff R. Angiogenesis and metastasis in breast tumors. Proceedings of the Sixth World Congress for Microcirculation (1996) 23-26
19. Cheung A.T.W., Chao C.Y., Young L.T.J., Chen P.C.Y., Ndoye A., Chanberlain S.R., Muller W.J., and Cardiff R.D. Angiogenesis, microvessel density and metastasis in a metastatic mammary tumor model. Int. J. Oncol. 11 (1997) 69-77
20. Cohen J.C., Traina V.L., Breznik T., and Gardner M. Development of a mouse mammary tumor virus-negative mouse strain: A new system for the study of mammary carcinogenesis. J. Virol. 44 (1982) 882-885
21. Cohen J.C., and Varmus H.E. Endogenous mammary tumour virus DNA varies among wild mice and segregates during inbreeding. Nature 278 (1979) 418-423
22. Cunha G.R. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 74 (1994) 1030-1044
23. Daniel C.W., De Ome K.B., Young J.T., Blair P.B., and Faulkin Jr. L.J. The in vivo life span of normal and preneoplastic mouse mammary glands: A serial transplantation study. Proc. Natl. Acad. Sci. U. S. A. 61 (1968) 53-60 1
24. Daniel C.W., and Robinson S.D. Regulation of mammary growth and function by TGF-β. Mol. Reprod. Dev. 32 (1992) 145-151
25. Deckard-Janatpour K., Muller W.J., Chodosh L., Coffey R.J., and Cardiff R.D. Differential expression of the neu transgene in murine mammary tissues. Int. J. Oncol. 11 (1997) 235-244
26. Dickson R.B., Gottardis M., and Merlino G.T. Molecular insights into breast cancer from transgenic mouse models. Bioessays 13 (1991) 591-596
27. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery Jr. C.A., Butel J.S., and Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 (1992) 215-221
28. Drohan W., Cardiff R.D., Lund J.K., and Schlom J. The use of nucleic acid hybridization to detect pulmonary metastases in mice bearing spontaneous mammary tumors. Can. Res. 40 (1980) 2316-2322
29. Dunn T.B. Morphology of mammary tumors in mice. In: Homburger F. (Ed). Physiopathology of Cancer (1959), A. J. Phiebig, Boston, Dordrecht, and Lancaster 38-83
30. Dupont W.D., and Page D.L. Risk factors for breast cancer in women with proliferative breast disease. New Eng. J. Med. 312 (1985) 146-151
31. Fantl V., Stamp G., Andrews A., Rosewell I., and Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 19 (1995) 2364-2372
32. Faulkin L.J., Mitchell D.J., Young L.J.T., Morris D.W., Malone R.W., Cardiff R.D., and Gardner M.B. Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus. J. Natl. Cancer Inst. 73 (1984) 971-982
33. Foulds L. The histologic analysis of mammary tumors of mice. II. The histology of responsiveness and progression. The origins of tumors. J. Natl. Cancer Inst. 17 (1956) 713-753
34. Foulds L. Neoplastic development (1969), Academic Press, New York
35. Gallahan D., Escot C., Hogg E., and Callahan R. Mammary tumorigenesis in feral species of the genus Mus. Curr. Top. Microbiol. Immunol. 127 (1986) 354-361
36. Gardner M.B., Malone R.W., Morris D.W., Faulkin L.J., Mitchell D.J., Young L.J.T., Strange R., and Cardiff R.D. Mammary tumors in feral mice lacking MuMTV DNA. J. Exp. Path. 2 (1985) 93-98
37. Groner B. Oncogene expression in mammary epithelial cells [see comments]. J. Cell. Biochem. 49 (1992) 128-136
38. Guy C.T., Cardiff R.D., and Muller W.J. Induction of metastatic mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12 (1992) 954-961
39. Guy C.T., Webster M.A., Schaller M., Parsons T.J., Cardiff R.D., and Muller W.J. Expression of the c-neu proto-oncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 10578-10582
40. Guy C.T., Muthuswamy S.K., Soriano P., Cardiff R.D., and Muller W.J. Activation of c-src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 8 (1994) 23-32
41. Guy C.T., Cardiff R.D., and Muller W.J. Activated neu induces rapid tumor progression. J. Biol. Chem. 271 (1996) 7673-7678
42. Halter S.A., Dempsey P., Matsui Y., Stokes M.K., Graves-Deal R., Hogan B.L., and Coffey R.J. Distinctive Patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-α. Characterization of mammary gland and skin proliferations. Am. J. Path. 149 (1992) 1131-1146
43. Hennighausen L., McKnight R., Burdon T., Baik M., Wall R.J., and Smith G.H. Whey acidic protein extrinsically expressed from the mouse mammary tumor virus long terminal repeat results in hyperplasia of the coagulation gland epithelium and impaired mammary development. Cell Growth Differ. 5 (1994) 607-613
44. Humphreys R.C., Krajewska M., Krnacik S., Jaeger R., Weiher H., Krajewski S., Reed J.C., and Rosen J.M. Apoptosis in the terminal endbud of the murine mammary gland: A mechanism of ductal morphogenesis. Development 12 (1996) 4013-4022
45. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachi S., Bronson R.T., and Weinberg R.A. Tumor spectrum analysis in p53 mutant mice. Curr. Biol. 4 (1994) 1-7
46. Jensen H.M., Rice J.R., and Wellings S.R. Preneoplastic lesions in the human breast. Science 191 (1976) 295-297
47. Jensen H.M., and Wellings S.R. Preneoplastic lesions of the human mammary gland transplanted into the nude athymic mouse. Cancer Res. 36 (1976) 2605-2610
48. Jhappan C., Gallahan D., Stahle C., Chu E., Smith G.H., Merlino G., and Callahan R. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev. 6 (1992) 345-355
49. Krane I.M., and Leder P. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene. 128 (1996) 1781-1788
50. Kwan H., Pecenka V., Tsukamoto A., Parslow T.G., Guzman R., Lin T.P., Muller W.J., Lee F.S., Leder P., and Varmus H.E. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol. and Cell Biol. 12 (1992) 147-154
51. Li, Li B., Greenberg N., Stephens L.C., Meyn R., Medina D., and Rosen J.M. Preferential overexpression of a 172Arg→Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. Cell Growth Differ. 7 (1994) 711-721
52. Li, Li M., Liu X., Robinson G., Bar-Peled U., Wagner K.U., Young W.S., Hennighausen L., and Furth P.A. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc. Natl. Acad. Sci. USA 94 (1997) 3425-3430 7
53. Lin T.P., Guzman R.C., Osborn R.C., Thordarson G., and Nandi S. Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia in Wnt-1 transgenic mice. Cancer Res. 52 (1992) 4413-4419
54. Lodato R.F., Maguire Jr. H.C., Greene M.I., Weiner D.B., and LiVolsi V.A. Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Mod. Pathol. 3 (1990) 449-454
55. Mangues R., Seidman I., Gordon J.W., and Pellicer A. Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice. Oncogene. 7 (1992) 2073-2076
56. Matsui Y., Halter S.A., Holt J.T., Hogan B.L., and Coffey R.J. Development of mammary hyperplasia and neoplasia in MMTV-TGF α transgenic mice. Cell 61 (1990) 1147-1155
57. Medina D. Mammary tumors. In: Foster S.L., Small J.D., and Fox J.G. (Eds). The mouse in Biomedical Research (1982), Academic Press, London, New York 373-396
58. Morris D.W., and Cardiff R.D. The multistep model of mouse mammary tumor development. Adv. Viral Oncol. 7 (1987) 123-140
59. Morris D.W., Barry P.A., Bradshaw H.D., and Cardiff R.D. Insertion mutagenesis of the int-1 and int-2 loci by mouse mammary tumor virus in premalignant and malignant neoplasms from the GR mouse strain. J. Virol. 64 (1990) 1794-1802
60. Morris D.W., and Cardiff R.D. The multistep model of mouse mammary tumor development. Adv. in Viral. Oncol. 7 (1987) 123-140
61. Muller W.J., Lee F.S., Dickson C., Peters G., Pattengale P., and Leder P. The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J. 9 (1990) 907-913
62. Muller W.J. Expression of activated oncogenes in the murine mammary gland: Transgenic models for human breast cancer. Cancer Metastasis Rev. 10 (1991) 217-227
63. Muller W.J., Sinn E., Pattengale P.K., Wallace R., and Leder P. Single step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54 (1988) 105-115
64. Muller W.J., Arteaga C.L., Muthuswamy S.K., Siegel P.M., Webster M.A., Cardiff R.D., Meise K.S., Li F., Halter S.A., and Coffey R. Synergistic interaction of the Neu protooncogene and TGFα in the mammary epithelium of transgenic mice. Mol. Cell. Biol. 16 (1996) 5726-5736
65. Munn R.J., Webster M., Muller W.J., and Cardiff R.D. Histopathology of transgenic mouse mammary tumorigenesis (A Short Atlas). Seminars in Cancer Biology 6 (1995) 153-158
66. Muthuswamy S.K., Siegel P.M., Dankort D.L., Webster M.A., and Muller W.J. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Mol. Cell. Biol. 14 (1994) 735-743
67. Ornitz D.J., Moreadith R.W., and Leder P. Binary system for regulating transgene expression in Mice: Targeting int-2 expression with yeast GAL4/UAS control elements. Proc. Natl. Acad. Sci. USA 88 (1991) 698-702
68. Ornitz D.M., Cardiff R.D., Kuo A., and Leder P. Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants. J. Natl. Cancer Inst. 84 (1992) 887-892
69. Page D.L. Pathology of preinvasive and early breast cancer. Curr. Opin. Oncol. 1 (1989) 277-283
70. Paigen K. A miracle enough: The power of mice. Nature Medicine 1 (1995) 215-220
71. Pierce Jr. D.F., Johnson M.D., Matsui Y., Robinson S.D., Gold L.I., Purchio A.F., Daniel C.W., Hogan B.L., and Moses H.L. Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β 1. Genes Dev. 7 (1993) 2308-2317
72. Pingitore R., and Squartini F. Relationships between morphology and viral etiology in mammary tumors of BALB/cfC3H and BALB/cfRIII mice. Tumori 68 (1982) 199-203
73. Robinson G.W., Smith G.H., Gallahan D., Zimmer A., Furth P.A., and Henninghausen L. Understanding mammary gland development through the imbalanced expression of growth regulators. Dev. Dyn. 206 2 (1996) 159-168
74. Sakai S., Mizuno M., Harigaya T., Yamamoto K., Mori T., Coffey R.J., and Nagasawa H. Cause of failure of lactation in mouse mammary tumor virus/human transforming growth factor α transgenic mice. Proc. Soc. Exp. Biol. Med. 205 (1994) 236-242
75. Schedin P.J., Thackray L.B., Malone P., Fontaine S.C., Friis R.R., and Strange R. Programmed cell death and mammary neoplasia. Cancer Treat. Res. 83 (1996) 3-22
76. Siegel P.M., Dankort D.L., Hardy W.R., and Muller W.J. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol. Cell. Biol. 14 (1994) 7068-7077
77. Squartini F., Bistocchi M., and Buongiorno L. Development, morphology, and progression of mammary tumors during and after fertile life in BALB/cfRIII mice. J. Natl. Cancer Inst. 66 (1981) 311-319
78. Squartini F., Basolo F., and Bistocchi M. Lobuloalveolar differentiation and tumorigenesis: two separate activities of mouse mammary tumor virus. Cancer Res. 43 (1983) 5879-5882
79. Strange R., and Cardiff R.D. Transgenic animals and transgenic mammary glands. In: Rich M.A., Hager J.C., and Keydar I. (Eds). Breast Cancer Progress in Biology, Clinical Management and Prevention (1989), Kluwer Academic Publishers, New York 1-14
80. Sympson C.J., Talhouk R.S., Alexander C.M., Chin J.R., Clift S.M., Bissell M.J., and Werb Z. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell. Biol. 125 (1994) 681-693
81. Tehranian A., Morris D.W., Min B.H., Bird D.J., Cardiff R.D., and Barry P.A. Neoplastic transformation of prostatic and urogenital epithelium by the Polyoma virus Middle T gene. Am. J. Path. 149 (1996) 1177-1191
82. Trimble M.S., Xin J.H., Guy C.T., Muller W.J., and Hassell J.A. PEA3 is overexpressed in mouse metastatic mammary adenocarcinoma. Oncogene 8 (1993) 3037-3042
83. Tsukamoto A.S., Grosschedl R., Guzman R.C., Parslow T., and Varmus H.E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55 (1988) 619-625
84. Tulchin N., Lee F.S., Ornstein L., Strauchen J., and Cardiff R.D. c-myc protein distribution: Mammary adenocarcinomas of MTV/MYC transgenic mice. Int. J. Oncol. 7 (1995) 5-9
85. Wang T.C., Cardiff R.D., Zuckerberg L., Lees E., Arnold A., and Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 (1994) 669-671
86. Webster M.A., and Muller W.J. Mammary tumorigenesis and metastasis in transgenic mice. Sem. Cancer Biol. 5 (1994) 69-76
87. Webster M.A., Cardiff R.D., and Muller W.J. Induction of mammary epithelia hyperplasias and mammary tumors in transgenic mice expressing an MMTV/activated c-src fusion gene. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7849-7853
88. Wellings S.R., Jensen H.M., and Marcum R.G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl. Cancer Inst. 55 (1975) 231-273